Publications

“It is beyond a doubt that all our knowledge begins with experience.” – Immanuel Kant

Melior Capital Management

PRESS RELEASE

Melior Insights – Q1 2020

A BRIEF REVIEW OF 2019 LIFE SCIENCE M&A ACTIVITY
What to expect in 2020?

BIG PHARMA PURSUIT OF NEW REVENUE STREAMSTHROUGH M&A
The case study of Eli Lilly.

FDA’S NEW DRUG APPLICATIONS APPROVED LIST
What is the focus of pharma companies?

Melior Insights – Special Report: COVID-19

IS THERE A SOLUTION FOR COVID-19?
The view of a life science professional with 40+ years of experience

LIFE SCIENCE MARKET FINANCIALS
What are the numbers telling us about the effects of COVID-19?

HOW ARE REGULATORY AGENCIES REACTING TO COVID-19?
The case study of the Food and Drug Administration (FDA)

THE LIFE SCIENCE INDUSTRY IN THE COVID-19 EPOCH
Critical questions for companies and investors

Melior Insights – May 2020

ARE WE ON THE VERGE OF A LIVER PANDEMIC?
A compelling story about life science investments

THE LIVER – THE LARGEST AND HEAVIEST INTERNAL ORGAN
One of the key organs with a long list of functions and roles

THE ECONOMICS OF LIVER DYSFUNCTION
How much does it cost us?

THE R&D INVESTMENTS FOCUSED ON LIVER DISEASE
Who is leading research and development in liver disease?

Melior Insights – June 2020

AN UNSPOKEN FEMALE HEALTH CARE CRISIS
A critical issue affecting millions, yet often ignored

STRESS URINARY INCONTINENCE (SUI)
A debilitating condition limiting the lives of millions of women

IS THERE A BETTER A WAY TO MANAGE SUI?
The revolutionary device that can give women back control of their life

Melior Insights – July 2020

THE LATEST THINKING ON LIFE SCIENCE INVESTMENTS
What makes life science so attractive to many investors

FIVE DRUGS THAT ARE SET TO BRING TENS OF BILLIONS IN SALES
The stories behind the future blockbuster drugs entering the market in 2020

FIVE MEDICAL DEVICE UPSTARTS TO WATCH
Companies that revolutionise medtech, will save lives and create investor value

COMPANIONS: PHARMACEUTICALS AND MEDICAL DEVICES
Two life science components

Melior Insights – August 2020

THE IMPORTANCE OF THE CARDIOVASCULAR SYSTEM
The functions of the cardiovascular system and conditions affecting it

THE ECONOMICS OF TREATING CARDIOVASCULAR CONDITIONS
What treatments are there and how much do they cost? A focus on cardiovascular devices.

THE DYNAMICS OF THE CARDIOLOGY MARKET
M&A, VC funding and IPOs of cardiology device companies

Melior Insights – September 2020

THE CURRENT STATE OF GLOBAL MARKETS
Are Private Equity investments the solution for generating exceptional returns?

M&A ACTIVITY IN THE FIRST 9 MONTHS OF 2020
What is the state of play in the context of “COVID-19”?

THE OUTLOOK FOR THE EUROPEAN M&A MARKET
Where are we going?

WHAT TO EXPECT FOR LIFE SCIENCE?
One of the most promising sectors in the current environment

CONTACT US NOW

CONNECT
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google